Abeona Therapeutics (ABEO) Other Accumulated Expenses (2021 - 2025)

Abeona Therapeutics' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $2000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses fell 96.88% year-over-year to $2000.0; the TTM figure through Dec 2025 stood at $2000.0 (down 96.88% YoY), while the FY2025 annual figure was $2000.0, down 96.88% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $2000.0, down from $35000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $317000.0 in Q1 2025, with the low at $1000.0 in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $72000.0 (2024), against an average of $115071.4.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses slumped 99.51% in 2024, then jumped 31600.0% in 2025.
• Abeona Therapeutics' Other Accumulated Expenses stood at $296000.0 in 2021, then slumped by 31.08% to $204000.0 in 2022, then slumped by 99.51% to $1000.0 in 2023, then jumped by 6300.0% to $64000.0 in 2024, then slumped by 96.88% to $2000.0 in 2025.
• Business Quant data shows ABEO's Other Accumulated Expenses at $2000.0 in Q4 2025, $35000.0 in Q3 2025, and $80000.0 in Q2 2025.